$70.0 Million
Inovio Pharmaceuticals, Inc.
Convertible Offering
Left Bookrunner
$46.0 Million
OptiNose AS
Confidentially Marketed Follow-On Offering
Left Bookrunner
$75.0 Million
CymaBay Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$101.2 Million
Repare Therapeutics Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$85.0 Million
Sutro Biopharma, Inc.
Initial Public Offering
Active Bookrunner
$86.3 Million
aTyr_New
aTyr Pharma Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$45.0 Million
Immunic, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$30.1 Million
Otonomy, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$129.0 Million
Savara Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$64.6 Million
Jounce Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.